Effective April 1, 2021, ThyGeNEXT® will be billed with Proprietary Laboratory Analysis (PLA) CPT code 0245U
Oncology (thyroid), mutation analysis of 10 genes and 37 RNA fusions and expression of 4 mRNA markers using next-generation sequencing, fine needle aspirate, report includes associated risk of malignancy expressed as a percentage.
Simple Ordering Process
Request complimentary ThyGeNEXT®/ThyraMIR®v2 Sample Collection Kits
Collect a specimen for testing when performing FNA
Added Convenience of Testing from Cytology Slides
Mail back the samples and requisition form
Interpace allows clients to use their own local cytopathology services. For those customers looking for an alternate option, Interpace offers comprehensive cytology services via our partner laboratories, including our National provider Dianon (LabCorp).
ThyGeNEXT + ThyraMIRv2 Test Process
FNA sample within provided collection buffer or PAP-stained smear, DiffQuik®, Giemsa-stained, and ThinPrep® Slides
Total Nucleic Acid Extraction
ThyGeNEXT testing with reflex to ThyraMIRv2 when needed
Result Report Sent to Client